Clinical trials aimed at HIV cure or remission: new pathways and lessons learned
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical trials aimed at HIV cure or remission: new pathways and lessons learned
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume -, Issue -, Pages 1-17
Publisher
Informa UK Limited
Online
2023-10-20
DOI
10.1080/14787210.2023.2273919
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A CRISPR-Cas Cure for HIV/AIDS
- (2023) Mouraya Hussein et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phenotypic signatures of immune selection in HIV-1 reservoir cells
- (2023) Weiwei Sun et al. NATURE
- HIV silencing and cell survival signatures in infected T cell reservoirs
- (2023) Iain C. Clark et al. NATURE
- HIV-1 remission and possible cure in a woman after haplo-cord blood transplant
- (2023) Jingmei Hsu et al. CELL
- In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation
- (2023) Björn-Erik Ole Jensen et al. NATURE MEDICINE
- Prevention, treatment and cure of HIV infection
- (2023) Raphael J. Landovitz et al. NATURE REVIEWS MICROBIOLOGY
- Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy
- (2023) Chris Y. Chiu et al. Frontiers in Immunology
- Monocyte-derived macrophages contain persistent latent HIV reservoirs
- (2023) Rebecca T. Veenhuis et al. Nature Microbiology
- Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates
- (2023) Tricia H. Burdo et al. GENE THERAPY
- Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial
- (2023) Jesper D. Gunst et al. NATURE MEDICINE
- Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial
- (2022) Jeffrey S. Miller et al. NATURE MEDICINE
- Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy
- (2022) Thomas S. Uldrick et al. Science Translational Medicine
- Immune checkpoint blockade in HIV
- (2022) Celine Gubser et al. EBioMedicine
- Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial
- (2022) Henning Gruell et al. Lancet Microbe
- Combination anti-HIV antibodies provide sustained virological suppression
- (2022) Michael C. Sneller et al. NATURE
- Prolonged viral suppression with anti-HIV-1 antibody therapy
- (2022) Christian Gaebler et al. NATURE
- Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial
- (2022) Joseph P. Casazza et al. NATURE MEDICINE
- Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial
- (2022) Boris Julg et al. NATURE MEDICINE
- Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART
- (2022) Catherine R. Cochrane et al. ANNALS OF NEUROLOGY
- Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques
- (2022) Victoria E. K. Walker-Sperling et al. Nature Communications
- Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial
- (2022) Jesper D. Gunst et al. NATURE MEDICINE
- Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial
- (2022) Lucia Bailón et al. NATURE MEDICINE
- The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse Model
- (2022) Aswath P. Chandrasekar et al. JOURNAL OF VIROLOGY
- Impact of anti-PD-1 and anti-CTLA-4 on the HIV reservoir in people living with HIV with cancer on antiretroviral therapy: The AIDS Malignancy Consortium-095 study
- (2021) Thomas A Rasmussen et al. CLINICAL INFECTIOUS DISEASES
- TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption
- (2021) Denise C. Hsu et al. PLoS Pathogens
- Suspected Immune-Related Adverse Events with an Anti-PD-1 Inhibitor in Healthy People with HIV
- (2021) Cynthia L. GAY et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Broadly neutralizing antibodies for HIV-1 prevention and therapy
- (2021) Boris Julg et al. SEMINARS IN IMMUNOLOGY
- The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy
- (2021) Devi SenGupta et al. Science Translational Medicine
- Therapeutic Potential of IL-15 and N-803 in HIV/SIV Infection
- (2021) Olivia Harwood et al. Viruses-Basel
- Viral, inflammatory, and reservoir characteristics of posttreatment controllers
- (2021) James McMahon et al. Current Opinion in HIV and AIDS
- The Interplay Among HIV, LINE-1, and the Interferon Signaling System
- (2021) Xu Zhao et al. Frontiers in Immunology
- Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic
- (2021) David A. Spencer et al. Frontiers in Public Health
- In Vivo Dynamics of the Latent Reservoir for HIV-1: New Insights and Implications for Cure
- (2021) Janet D. Siliciano et al. Annual Review of Pathology-Mechanisms of Disease
- Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat
- (2021) Cynthia L Gay et al. JOURNAL OF INFECTIOUS DISEASES
- Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial
- (2021) Kathryn E. Stephenson et al. NATURE MEDICINE
- Interleukin-7 Biology and Its Effects on Immune Cells: Mediator of Generation, Differentiation, Survival, and Homeostasis
- (2021) Deng Chen et al. Frontiers in Immunology
- Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial
- (2020) Sarah Fidler et al. LANCET
- Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity
- (2020) Julia Niessl et al. NATURE MEDICINE
- Different human resting memory CD4+ T cell subsets show similar low inducibility of latent HIV-1 proviruses
- (2020) Kyungyoon J. Kwon et al. Science Translational Medicine
- BCL-2 antagonism sensitizes cytotoxic T cell–resistant HIV reservoirs to elimination ex vivo
- (2020) Yanqin Ren et al. JOURNAL OF CLINICAL INVESTIGATION
- CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption
- (2020) Justin Harper et al. NATURE MEDICINE
- HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02)
- (2020) Beatriz Mothe et al. Frontiers in Immunology
- Combination of CD8β depletion and IL-15 superagonist N-803 induces virus reactivation in SHIV-infected, long-term ART-treated rhesus macaques
- (2020) Julia B. McBrien et al. JOURNAL OF VIROLOGY
- HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs In Vitro and Ex Vivo
- (2020) Andrew Timmons et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies
- (2020) Janne Tegder Martinsen et al. Frontiers in Immunology
- Vesatolimod, a toll-like receptor 7 agonist, induces immune activation in virally suppressed adults with HIV-1
- (2020) Sharon A Riddler et al. CLINICAL INFECTIOUS DISEASES
- Safety, immune and anti-viral effects of pegylated interferon alpha 2b administration in ART-suppressed individuals: Results of pilot clinical trial
- (2020) Emmanouil Papasavvas et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor–Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis
- (2020) Silvia Bertagnolio et al. JOURNAL OF INFECTIOUS DISEASES
- Antigen-driven clonal selection shapes the persistence of HIV-1–infected CD4+ T cells in vivo
- (2020) Francesco R. Simonetti et al. JOURNAL OF CLINICAL INVESTIGATION
- Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure
- (2020) Janet D Siliciano et al. JOURNAL OF INFECTIOUS DISEASES
- Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency
- (2019) Zichong Li et al. PLoS Pathogens
- HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
- (2019) Ravindra K. Gupta et al. NATURE
- Effects of 24 Week Toll-Like Receptor 9 Agonist Treatment in HIV-1+ Individuals
- (2019) Line K. Vibholm et al. AIDS
- Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial
- (2019) Trevor A Crowell et al. Lancet HIV
- NK Response Correlates with HIV Decrease in Pegylated IFN-α2a–Treated Antiretroviral Therapy–Suppressed Subjects
- (2019) Emmanouil Papasavvas et al. JOURNAL OF IMMUNOLOGY
- TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes
- (2019) Mariane H. Schleimann et al. EBioMedicine
- The Role of the BCL-2 Family of Proteins in HIV-1 Pathogenesis and Persistence
- (2019) Aswath P. Chandrasekar et al. CLINICAL MICROBIOLOGY REVIEWS
- The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation
- (2019) Melissa-Rose Abrahams et al. Science Translational Medicine
- T‐cell exhaustion in HIV infection
- (2019) Craig Fenwick et al. IMMUNOLOGICAL REVIEWS
- Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency
- (2018) Vanessa A. Evans et al. AIDS
- HIV-1 Infection and Type 1 Interferon: Navigating through Uncertain Waters
- (2018) Sho Sugawara et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection
- (2018) E P Scully et al. ANNALS OF ONCOLOGY
- An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients
- (2018) Elizabeth Colston et al. PLoS One
- TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy
- (2018) So-Yon Lim et al. Science Translational Medicine
- CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures
- (2018) Youdiil Ophinni et al. Scientific Reports
- Combination therapy with anti-HIV-1 antibodies maintains viral suppression
- (2018) Pilar Mendoza et al. NATURE
- Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
- (2018) Yotam Bar-On et al. NATURE MEDICINE
- Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
- (2018) Erica N. Borducchi et al. NATURE
- A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
- (2018) Daniel B. Reeves et al. Nature Communications
- Anti-retroviral antibody FcγR-mediated effector functions
- (2017) Stylianos Bournazos et al. IMMUNOLOGICAL REVIEWS
- Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency
- (2017) Nancie M. Archin et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy
- (2017) Cynthia L. Gay et al. JOURNAL OF INFECTIOUS DISEASES
- ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment
- (2017) Amy L. Ellis-Connell et al. JOURNAL OF VIROLOGY
- Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy
- (2017) Angela Tsai et al. JOURNAL OF VIROLOGY
- The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon
- (2017) A R Krarup et al. Mucosal Immunology
- Early antibody therapy can induce long-lasting immunity to SHIV
- (2017) Yoshiaki Nishimura et al. NATURE
- Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
- (2017) Marina Caskey et al. NATURE MEDICINE
- Heat Shock Protein 90 Facilitates Latent HIV Reactivation through Maintaining the Function of Positive Transcriptional Elongation Factor b (p-TEFb) under Proteasome Inhibition
- (2016) Xiao-Yan Pan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size
- (2016) Nathan W. Cummins et al. JOURNAL OF VIROLOGY
- A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+T Cells
- (2016) Rasmus Offersen et al. JOURNAL OF VIROLOGY
- PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals
- (2016) Riddhima Banga et al. NATURE MEDICINE
- Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
- (2016) Katharine J. Bar et al. NEW ENGLAND JOURNAL OF MEDICINE
- HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
- (2016) T. Schoofs et al. SCIENCE
- Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo
- (2016) C.-L. Lu et al. SCIENCE
- Initiation of antiretroviral therapy before detection of colonic infiltration by HIV reduces viral reservoirs, inflammation and immune activation
- (2016) Trevor A Crowell et al. Journal of the International AIDS Society
- A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells
- (2016) Judd F. Hultquist et al. Cell Reports
- TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection
- (2016) Glen M. Chew et al. PLoS Pathogens
- CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART
- (2016) Rémi Fromentin et al. PLoS Pathogens
- A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes
- (2016) R. Brad Jones et al. PLoS Pathogens
- Establishment and stability of the latent HIV-1 DNA reservoir
- (2016) Johanna Brodin et al. eLife
- Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial
- (2016) Steffen Leth et al. Lancet HIV
- HIV DNA Set Point is Rapidly Established in Acute HIV Infection and Dramatically Reduced by Early ART
- (2016) Jintanat Ananworanich et al. EBioMedicine
- Effect of ipilimumab on the HIV reservoir in an HIV-infected individual with metastatic melanoma
- (2015) Fiona Wightman et al. AIDS
- Understanding HIV Latency: The Road to an HIV Cure
- (2015) Matthew S. Dahabieh et al. Annual Review of Medicine
- Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts
- (2015) Wei Cao et al. CLINICAL INFECTIOUS DISEASES
- Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
- (2015) Marina Caskey et al. NATURE
- Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
- (2015) Kai Deng et al. NATURE
- Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
- (2015) Rebecca M. Lynch et al. Science Translational Medicine
- The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
- (2015) Ole S. Søgaard et al. PLoS Pathogens
- HIV-1 Expression Within Resting CD4+ T Cells After Multiple Doses of Vorinostat
- (2014) N. M. Archin et al. JOURNAL OF INFECTIOUS DISEASES
- Modeling the Timing of Antilatency Drug Administration during HIV Treatment
- (2014) J. Petravic et al. JOURNAL OF VIROLOGY
- Targeted genome editing in human repopulating haematopoietic stem cells
- (2014) Pietro Genovese et al. NATURE
- Measuring Turnover of SIV DNA in Resting CD4+ T Cells Using Pyrosequencing: Implications for the Timing of HIV Eradication Therapies
- (2014) Jeanette C. Reece et al. PLoS One
- Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
- (2014) F. Maldarelli et al. SCIENCE
- Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
- (2014) Julian H. Elliott et al. PLoS Pathogens
- Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
- (2014) Thomas A Rasmussen et al. Lancet HIV
- Interleukin-7 promotes HIV persistence during antiretroviral therapy
- (2013) C. Vandergeeten et al. BLOOD
- What the Infectious Disease Physician Needs to Know About Pegylated Interferon and Ribavirin
- (2013) N. Gara et al. CLINICAL INFECTIOUS DISEASES
- Susceptibility to CD8 T-Cell–Mediated Killing Influences the Reservoir of Latently HIV-1–Infected CD4 T Cells
- (2013) Maria J. Buzon et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Effects of Alpha Interferon Treatment on Intrinsic Anti-HIV-1 Immunity In Vivo
- (2013) M. Abdel-Mohsen et al. JOURNAL OF VIROLOGY
- HIV Latency
- (2013) R. F. Siliciano et al. Cold Spring Harbor Perspectives in Medicine
- Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
- (2013) Asier Sáez-Cirión et al. PLoS Pathogens
- Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
- (2012) Peter D. Kwong et al. IMMUNITY
- Pegylated Interferon Alfa-2a Monotherapy Results in Suppression of HIV Type 1 Replication and Decreased Cell-Associated HIV DNA Integration
- (2012) Livio Azzoni et al. JOURNAL OF INFECTIOUS DISEASES
- Cell-Based Measures of Viral Persistence Are Associated With Immune Activation and Programmed Cell Death Protein 1 (PD-1)–Expressing CD4+ T cells
- (2012) Hiroyu Hatano et al. JOURNAL OF INFECTIOUS DISEASES
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
- (2012) N. M. Archin et al. NATURE
- Shock and kill
- (2012) Steven G. Deeks NATURE
- Interferon-Alpha Administration Enhances CD8+ T Cell Activation in HIV Infection
- (2012) Maura Manion et al. PLoS One
- Role of retroviral restriction factors in the interferon- -mediated suppression of HIV-1 in vivo
- (2012) S. K. Pillai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques
- (2011) E. Lugli et al. BLOOD
- Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events
- (2011) S. Arastu-Kapur et al. CLINICAL CANCER RESEARCH
- Second Generation Proteasome Inhibitors: Carfilzomib and Immunoproteasome-Specific Inhibitors (IPSIs)
- (2011) D. J. Kuhn et al. CURRENT CANCER DRUG TARGETS
- Homeostatic Proliferation Fails to Efficiently Reactivate HIV-1 Latently Infected Central Memory CD4+ T Cells
- (2011) Alberto Bosque et al. PLoS Pathogens
- HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy
- (2010) Hiromi Imamichi et al. AIDS
- Role of Interleukin-2 in Patients with HIV Infection
- (2010) Sarah L. Pett et al. DRUGS
- Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity
- (2010) Thomas R. Malek et al. IMMUNITY
- Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa‐2a in HIV‐1–Monoinfected Participants: A Phase II Clinical Trial
- (2010) David M. Asmuth et al. JOURNAL OF INFECTIOUS DISEASES
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection
- (2009) I. Sereti et al. BLOOD
- Enhanced T cell recovery in HIV-1–infected adults through IL-7 treatment
- (2009) Yves Levy et al. JOURNAL OF CLINICAL INVESTIGATION
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
- (2009) Nicolas Chomont et al. NATURE MEDICINE
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started